The 40 Mb T1D susceptibility locus Iddm26 was mapped to chromosome 2 through linkage analysis of a conditioned crossintercross between the diabetes-prone BBDP and the diabetes-resistant ACI.BBDP-Iddm1,Iddm2 (ACI.1u.Lyp). It is flanked by Iddm32 and Iddm33, which control the kinetics of disease progression. To fine-map Iddm26 and characterize immune phenotypes controlled by this locus, several congenic sublines were generated carrying smaller, overlapping intervals spanning Iddm26 and fragments of Iddm32 and 33. Analysis of disease susceptibility, age of disease onset, and immune phenotypes in these sublines identified subloci regulating these different parameters. Two ACI.1u.Lyp-derived subloci, Iddm26.1 and Iddm26.2, imparted significant protection from diabetes, decreasing the cumulative incidence by as much as 57% and 28%, respectively. Iddm26.2, which overlaps with the human PTPN22 locus, only affected disease susceptibility, whereas Iddm26.1 also significantly affected disease kinetics, delaying T1D onset by more than 10 days compared with the parental BBDP strain. These Iddm26 subloci also regulated various immune phenotypes, including the proportion of splenic macrophages by Iddm26.1, and the proportion of activated T-cells in secondary lymphoid organs by Iddm26.2. The analysis of Iddm26 congenic animals in two different SPF facilities demonstrated that the influence of this locus on T1D is environment-dependent.
INTRODUCTION
A comprehensive genome-wide linkage analysis performed by Wallis et al. 1 on a conditional F2(BBDP Â ACI.1u.Lyp) cohort identified several T1D-associated loci throughout the rat genome, providing evidence for the complex, polygenic control of the diabetic syndrome in the BBDP rat model. Three adjacent and independent loci were identified on chromosome 2 alone, which exert different effects and influence over disease pathogenesis. A graph showing the log of odds (LOD) score for these Iddm loci plotted against the chromosomal position is shown in Figure 1 . Iddm32 is a centromeric, B75 Mb interval demarcated by D2Rat75 and D2Rat38 that was found to influence both the age of disease onset and islet integrity (defined as normal islet size and architecture). 1 Further towards the telomere is another age of onset (AOO) locus, Iddm33, which is a B33 Mb region located between D2Rat82 and D2Rat69. 1 At both of these loci, the ACI haplotype was protective and conferred a delay in the mean age of disease onset compared with the BBDP.
Located between the two AOO loci is a 40 Mb region designated as Iddm26. This region, which is the main focus here, influences T1D susceptibility and is demarcated by D2Rat44 and D2Rat88, with a peak of linkage at D2Arb16. 1 Interestingly, Iddm26 also overlaps with Iddm3 previously identified using a cross between the diabetes-prone DR lyp/lyp and the diabetes-resistant F344 strains, 2 which has not been fine-mapped. The region was also observed to regulate metabolism and body weight following fasting in the same cross, 2 suggesting that it may be involved in multiple pathways that contribute to the diabetic process. Several genes involved in the regulation of both innate and adaptive immune responses are located within Iddm26, providing multiple potential candidates as causal variants.
To identify the region(s) responsible for the control of T1D susceptibility, it is necessary to narrow the interval of interest through the use of congenic sublines. In this study, we describe and phenotype several congenics, which carry smaller and overlapping fragments of Iddm26. This methodology allowed for the identification of multiple intervals influencing T1D risk, disease kinetics, and other immune phenotypes possibly contributing to disease susceptibility.
RESULTS
Evidence for multiple T1D loci on rat chromosome 2 To characterize the genetic loci that affect T1D development within the large chromosome 2 interval, six BBDP congenic lines were generated that carry different overlapping ACI.1u.Lypderived segments (Figure 2a) . The 2BA and 2BAfii congenic lines carry a 104 Mb region derived from the ACI.1u.Lyp into the BBDP genetic background, which encompass both Iddm26 and 33, as well as a small fragment of Iddm32, but differ at a 2.6 Mb interval between D2Rat99 and D2Rat354. As both Iddm32 and 33 influence only AOO, but not T1D-susceptibility, the inclusion of all or parts of these two genetic regions was not expected to affect the ability to detect the effect of Iddm26 on disease risk. The 2BAb and 2BAc lines carry the centromeric region of Iddm26 and a fragment of Iddm32, whereas the 2BAa and 2BAe lines focus on the telomeric Iddm26 region and the centromeric fragment of Iddm33. These sublines, along with the BBDP and ACI.1u.Lyp parental strains, were all housed under SPF conditions at the Ontario Cancer Institute (OCI) Animal Resource Centre (Toronto, ON, Canada), and subsequently monitored for diabetes onset for up to 140 days to compare the cumulative disease incidences of the different sublines to that of the parental BBDP strain.
The 2BAb and 2BAc congenic lines carry ACI.1u.Lyp-derived chromosome 2 intervals encompassing small telomeric fragments of Iddm32, as well as the centromeric region of Iddm26. Both carry the ACI haplotype from D2Mit8 (169 Mb) to D2Arb16 (225 Mb). However, the 2BAc carries a slightly longer fragment that extends to D2Rat354 (226.4 Mb). Compared with the BBDP, which exhibited a cumulative diabetes incidence of 84.6% (n ¼ 65), both the 2BAb and the 2BAc exhibited significant protection from diabetes ( Figure 2b) , with cumulative incidences of 48.1% (n ¼ 52) and 36.7% (n ¼ 30), respectively (Po0.0001 Fisher's exact test and Mantel-Cox). Neither the survival curve nor the cumulative incidences of the 2BAb and 2BAc congenic lines were significantly different from each other (P ¼ 0.68 Mantel-Cox, P ¼ 0.36 Fisher's exact test). This finding would suggest that a locus lies within the 56 Mb interval shared by the two congenic lines that strongly influences T1D risk, which will henceforth be referred to as Iddm26.1 (Figure 2a) .
The 2BAa and the 2BAe congenic lines were generated to examine the effects of the telomeric fragment of Iddm26 and the centromeric region of Iddm33 on the development of diabetes. Both lines share a 30.7 Mb ACI.1u.Lyp-derived fragment demarcated by D2Rat50 (227 Mb) and D2Rat63 (257.7 Mb). However, the 2BAa line carries a slightly longer interval that extends further centromeric to D2Arb16 (225 Mb). As illustrated in Figure 2c , the 2BAa congenic line was significantly protected from diabetes, with a cumulative incidence of 60.6% (n ¼ 33, P ¼ 0.008 Fisher's exact test, P ¼ 0.005 Mantel-Cox) compared with the BBDP line. However, despite differing only at a 2 Mb interval, the 2BAe line remained highly susceptible to T1D, with a cumulative disease incidence of 85.4% (n ¼ 41), which was not significantly different from that of the BBDP (Figure 2c , P ¼ 1.0 Fisher's exact test, P ¼ 0.40 Mantel-Cox). This finding provides evidence for a second T1D sublocus, Iddm26.2, within the 2 Mb interval, which distinguishes the 2BAa and 2BAe congenic lines ( Figure 2a) .
As illustrated in Figure 2d , the 2BA line carrying the full chromosome 2 fragment had a cumulative incidence of 77.8% (n ¼ 45), which was not significantly different from the BBDP (P ¼ 0.45 Fisher's exact test). The same is observed in the 2BAfii, which carries a similar ACI.1u.Lyp-derived region, except at a 2.6 Mb interval between D2Rat99 (223.8 Mb) and D2Rat354 (226.4 Mb), which is BBDP-derived in this congenic line. Specifically, the 2BAfii had a cumulative diabetes incidence of 66.7% (n ¼ 27), which is not significantly different from the BBDP (P ¼ 0.087 Fisher's exact test) and the 2BA (P ¼ 0.41 Fisher's exact test, Figure 2d ). Although the diabetes incidence in both the 2BA and 2BAfii congenic lines did not differ from the BBDP, their survival curves showed significant difference from the parental strain due to a delay in diabetes onset (P ¼ 0.0009 and P ¼ 0.01, respectively, Mantel-Cox analysis).
The absence of significant protection from the disease in both 2BA and 2BAfii lines would suggest that gene-gene interactions are potentially at play between the Iddm26.1 sublocus and another modifying locus contained within the telomeric end of the chromosomal region only shared by these two lines. Individually or in combination with Iddm26.2, its protective effect can be observed, as in the case of the 2BAb and 2BAc congenic lines. However, in the presence of the modifying locus, the effects of the Iddm26.1 locus on disease protection appear to be negated (Figure 2a ).
Identification of AOO loci
The mean ages of disease onset were determined for the BBDP parental strain and various congenic sublines by calculating the average age at T1D diagnosis of diabetic animals. Kruskal-Wallis analysis of the parental and congenic lines followed revealed a significant difference among the groups (Po0.0001). To subsequently identify the region(s) controlling disease kinetics, MannWhitney test was performed to compare the AOO of the different sublines to that of the BBDP, and also to sublines carrying similar genetic intervals.
Compared with the BBDP, both congenic sublines carrying the centromeric, ACI.1u.lyp-derived fragment showed striking and significant delays in T1D onset ( Figure 3, Supplementary Figure 1) . The BBDP had a mean AOO of 80.8 days, which is significantly lower than the 93.7 days observed in the 2BAb (P ¼ 0.0001) and the 90.1 days observed in the 2BAc (P ¼ 0.0085). This would suggest that the 56 Mb ACI.1 u.Lyp-derived Iddm26.1 locus shared by the two lines has a strong influence on disease kinetics.
Examination of the 2BAa and 2BAe congenic lines, which only carry ACI.1u.Lyp-derived telomeric fragments reveal a trend towards a mild delay in disease onset compared with the BBDP. The 2BAa had a mean AOO of 84.2 days (P ¼ 0.11), whereas the 2BAe showed a slight, but significant delay compared with the parental strain with a mean age of 85.1 days (P ¼ 0.046). Secondary analysis pooling AOO of the congenic sublines carrying the telomeric chromosome 2 fragment (Supplementary Figure 2) , showed significant difference from the BBDP, with a mean AOO of 84.8 days (P ¼ 0.047). This potentially points to another AOO locus on the telomeric end within the 30.7 Mb region between D2Rat50 and D2Rat63 with a milder effect. However, these findings lose significance upon adjustment of P-value thresholds by Bonferroni correction (Po0.0083).
Studies on the 2BA and the 2BAfii congenic sublines provide evidence, which can potentially further narrow the causative AOO locus located on the centromeric region. Both lines exhibit a delay compared with the BBDP parental strain (Po0.0001 and P ¼ 0.028, respectively). However, their mean AOOs also differ significantly from each other (P ¼ 0.049) despite the small 2.6 Mb size of the chromosome 2 interval between D2Rat99 and D2Rat354 that distinguishes them. Although the 2BA line exhibits a delay Figure 1 . Iddm loci located on rat chromosome 2. Three Iddm loci were identified through genetic association studies performed on an F2(BBDP ÂACI.1u.Lyp) cohort. The shaded regions on the graph indicate the extents of their 1-LOD intervals. Iddm32 and 33 control the age of disease onset, whereas Iddm26 influences T1D susceptibility. The graph shows the log of odds (LOD) score on the y-axis and the chromosomal position on the x-axis in Mb.
consistent with that of the 2BAb and 2BAc congenic lines, with a mean AOO of 91.8 days, the 2BAfii line has an AOO of 85.7days similar to that observed in the 2BAa and 2BAe lines. The causal 2.6 Mb region can be dissected further through the examination of areas of overlap between the 2BAfii and 2BAb congenic intervals. This analysis identifies a 1.2 Mb interval potentially responsible for the control of disease kinetics and age of T1D onset located between D2Rat99 and D2Arb16.
Other immune phenotypes controlled by rat chromosome 2 loci Type 1 diabetes is an organ-specific, T cell-mediated autoimmune disorder. However, several immune cell types, including B cells and macrophages, also participate in the inflammatory response and have been identified in insulitic lesions. 3, 4 Therefore, the contributions of the various chromosome 2 regions on immune subphenotypes possibly relevant to T1D pathogenesis were assessed through flow cytometric and serological analyses in 140-day-old congenic and parental strains. All studies were performed on nondiabetic animals to rule out the potential effects of the metabolic changes associated with T1D on the immune system. Of note, all animals studied here were homozygous for the null mutation of Gimap5, the causal variant of Iddm2 in the BBDP rat, and were therefore T lymphopenic. This T lymphopenia is not observed in the human disease. However, partial immunodeficiency, including in the T-cell lineage, is associated with multiple autoimmune syndromes in humans (reviewed in Liston et al. 5 ).
Thymic cellularity. Defects in T-cell development and central tolerance mechanisms in the thymus can promote the export of potentially autoreactive T-cells in the periphery, and regulate the size and repertoire of the peripheral T-cell pool. To examine whether there is evidence for altered thymocyte development, thymic cellularity was quantified in the congenic sublines, as well as the parental ACI.1u.Lyp and BBDP strains (Figure 4a ). This revealed a significant decrease in cell numbers in 2BA animals compared with the BBDP (P ¼ 0.0055), which was similar to the levels observed in the ACI.1u.Lyp (P ¼ 0.40). The 2BAb congenic animals carrying the centromeric fragment of the chromosome 2 interval exhibited thymic cellularity similar to that of the BBDP (P ¼ 0.69), thus eliminating this region as causal (Supplementary Figure 3) . However, the 2BAa congenic line, which carries a telomeric ACI.1u.Lyp-derived chromosome 2 fragment exhibited a thymic cellularity indistinguishable from that of the ACI.1u.Lyp (P ¼ 1), and significantly reduced compared with the BBDP (P ¼ 0.03). This would suggest that the causal gene or genes lie within this interval (Figure 4a ). The 2BAfii only differs from the 2BA line at a 2.6 Mb interval located between D2Rat99 and D2Rat354, where it has a BBDP genotype. However, examination of thymic cellularity revealed a significant difference between the two lines (P ¼ 0.04). Although the 2BA showed levels similar to the ACI.1u.Lyp, the 2BAfii had increased thymic cellularity similar to the BBDP (P ¼ 0.96). This would suggest that the 1.4 Mb region demarcated by D2Arb16 and D2Rat354, shared by both the 2BAa and 2BAfii congenic lines, exerts a strong effect on the thymic phenotype ( Figure 4b ). This observation is further supported by the increased thymic cellularity in the 2BAe congenic line compared with the 2BAa, which carries a similar ACI.1u.Lyp-derived telomeric fragment as the 2BAa, but has the BBDP genotype in this genetic interval (P ¼ 0.02, Figure 4a ). The observation that the 2BAc congenic subline exhibits a phenotype similar to the BBDP (P ¼ 0.49, Supplementary Figure 3 ) despite carrying the ACI.1u.Lyp-derived genetic interval would suggest that the penetrance of this phenotype is dependent upon genetic interactions of this locus with other genes located within the telomeric region (D2Rat354 to D2Rat63).
To determine whether the increased thymic cellularity conferred by this locus correlated with increased thymic output, the daily thymic production of recent thymic emigrants (RTEs) was assessed by performing fluorescein isothiocyanate (FITC) intrathymic injections on 40-day-old BBDP, ACI.1u.Lyp and reciprocal BBDP (2BA) or ACI.1u.Lyp congenic (2AB) (Supplementary Figure 4) animals. These animals were killed 24 h after the procedure to assess the absolute number of FITC þ RTE present in their secondary lymphoid organs. First, this analysis revealed that the chromosome 2 congenic interval influenced the thymic cellularity ( Figure 5a ). Thus, animals congenic for the BBDP chromosome 2 interval in the ACI.1u.Lyp genetic background had a significantly increased number of total thymocytes compared with the parental strain (P ¼ 0.0230), but did not differ from that observed in the BBDP animals (P ¼ 1.0). In contrast, the ACI.1u.Lypderived chromosome 2 interval had an opposite effect, resulting in decreased thymocyte cell numbers in 2BA congenic animals compared with its BBDP counterparts (P ¼ 0.0047). This is consistent with the phenotype observed in older, 140-day-old animals. A similar trend in total cellularity was observed in the spleen, although the difference between the BBDP and the 2BA congenic animals did not reach significance.
Furthermore, examination of the total number of FITC þ RTE in the spleen revealed the same pattern, with the BBDP and 2AB strains showing evidence for a significantly increased thymic output compared with the 2BA (P ¼ 0.0244) and ACI.1u.Lyp animals (P ¼ 0.0286), respectively ( Figure 5b ). Although not reaching statistical significance, the same general trend was observed in the lymph nodes. Of note, assessment of RTE cellularity could not be reliably performed for CD8 þ T-cells alone, as this subset accounts for less than 5% of total T-cells in all of these congenic and parental strains that carry the BBDP-derived Iddm2 locus responsible for a severe peripheral T lymphopenia. 6 
Activated peripheral CD4
þ CD25 þ T-cells. The null mutation of Gimap5 carried by the BBDP and all the congenic lines described in this study results in the precipitous apoptotic death of RTE unless they are rescued by antigenic activation. 7, 8 Consequently, homozygosity for this diabetogenic mutation is associated with a high proportion of activated cells among peripheral T-cells. 9 Therefore, the proportion of activated cells is not only an indication of immune reactivity; it also determines and shapes the size of the T-cell pool in these lymphopenic animals.
To gain insight into whether this phenotype is influenced by the chromosome 2 Iddm loci, the proportion of activated peripheral CD4 þ CD25 þ T-cells in the secondary lymphoid organs of the chromosome 2 congenic sublines was assessed. The 2BA congenic line exhibited proportions of CD4 þ CD25 þ T-cells similar to that of the 2BAfii (P ¼ 0.21), and was not significantly different from that of the parental BBDP strain (P ¼ 0.64) (Supplementary Figure 5) . However, comparison of the 2BAb line with the 2BAc, and the 2BAa line with the 2BAe (Figure 6a ) revealed significant differences in the proportion of CD4 þ CD25 þ T-cells in the lymph nodes of these animals (P ¼ 0.0098 and Po0.0001 respectively). Although the 2BAb and the 2BAe animals had proportions similar to that of BBDP rats (P ¼ 0.30 and P ¼ 0.23, respectively), both the 2BAa and 2BAc strains exhibited reduced proportions of this cell subset compared with the parental strain (P ¼ 0.0005 and P ¼ 0.0098, respectively). This would suggest that the chromosome 2 locus controlling this T-cell phenotype lies within the 1.4 Mb region shared by the two lines demarcated by D2Arb16 and D2Rat354 (Figure 6b ).
Splenic macrophages. Macrophages are among the first cells to infiltrate the pancreatic islets of diabetes-prone mice and rats, and there is evidence that their function is altered in these animals. [10] [11] [12] This led us to assess the homeostasis of this cell subset in the congenic lines described in this study. As illustrated in Figure 7a , comparison of the two parental lines revealed a significantly reduced proportion of splenic macrophages in the ACI.1u.Lyp compared with the BBDP (Po0.0001). Comparison of the 2BA and the 2BAfii with the BBDP (Supplementary Figure 6) did not reveal significant differences between the congenic lines and the parental strain (P ¼ 0.06 and P ¼ 0.21, respectively). Furthermore, analysis of the 2BAa and 2BAe chromosome 2 congenic sublines, which only carry the ACI.1u.Lyp-derived telomeric fragment, revealed that both the lines had similar proportions of splenic macrophages as the BBDP (P ¼ 0.32 and P ¼ 0.48, respectively), and remained significantly different from that of the ACI.1u.Lyp (P ¼ 0.002 and P ¼ 0.005, respectively). Contrary to the 2BAa and 2BAe, congenic sublines only carrying the centromeric ACI.1u.Lyp-derived fragments, the 2BAb and 2BAc, exhibited a significant decrease in macrophage proportions, similar to, but not quite to the same degree as that observed in the ACI.1u.Lyp. Compared with the parental BBDP strain, both the 2BAb (P ¼ 0.003) and 2BAc (P ¼ 0.04) had decreased proportions of splenic macrophages, suggesting that the region controlling this phenotype lies within the 56 Mb, Iddm26.1 region demarcated by D2Mit8 and D2Arb16 (Figure 7b) . It is noted, however, that despite the reduction in the cell population, the levels did not quite reach those of the ACI.1u.Lyp strain (P ¼ 0.008 and P ¼ 0.02 respectively). This finding indicates that other interacting genetic regions outside of this chromosome 2 interval may also influence macrophage populations in the spleen.
Serum immunoglobulin E. Partial immunodeficiency is characterized by an incomplete reduction in T-cell numbers, with or without an accompanying decrease in function and activity, such as the T lymphopenia of the BBDP rat due to the Gimap5 mutation. It has been observed that mild T-cell deficiency in humans is commonly accompanied by hyperimmune dys- , often characterized by autoimmunity and increased serum immunoglobulin E (IgE) levels, as observed in WiskottAldrich and DiGeorge (22q11) syndromes. 5 As IgE levels is indicative of immune dysregulation resulting from moderate T-cell deficiency, it was first quantified in the F2(BBDP Â ACI.1u.Lyp) cohort to determine whether chromosome 2 influenced the quantity of this Ig isotype in the serum. Analysis revealed an association of increased serum IgE levels with their genotype at the peak of T1D linkage on chromosome 2, D2Arb16 (Figure 8a ). The ACI.1u.Lyp genotype was associated with a decrease in serum IgE levels, and exerted a dominant effect over that of the BBDP. However, as recombinations between D2Arb16 adjacent regions were rare within the F2 cohort studied, it is uncertain whether this phenotype was due to genes in proximity to the marker itself, or other regions in linkage disequilibrium with D2Arb16.
Examination of serum IgE levels in the parental BBDP strain as well as the various congenic lines that followed revealed a significant reduction in the IgE levels of all congenic lines compared with the BBDP (Supplementary Figure 7) . Among all lines tested, the 2BA, which have the largest ACI.1u.Lyp-derived chromosome 2 interval had the lowest levels, and was significantly different from the 2BAa line carrying the ACI.1u.Lyp-derived telomeric fragment (P ¼ 0.01), and the 2BAb line carrying a nonoverlapping centromeric region (P ¼ 0.02). This would suggest that both the centromeric and telomeric fragments of the chromosome 2 interval carry causal genes or loci, which can control this phenotype and function independently of each other (Figure 8b) . However, the two can also work in synergy to exert a greater effect on the suppression of IgE production, as observed in the 2BA line. It can therefore be surmised that the centromeric fragment responsible lies within the 56 Mb . ACI-derived chromosome 2 region confers T1D resistance, in an environment-dependent manner. The survival curves of the BBDP and 2BA strains followed concurrently at the SRI (solid line) and OCI (dashed line) animal facilities are shown (***Po0.001, Mantel-Cox analysis log-rank statistic). Mean age of disease onset is indicated for each strain at both institutions. For a given strain, the age of onset was similar between the two locations. However, at each institution, the age of onset in the 2BA strain was significantly higher than that of the BBDP animals (Po0.0001 at OCI and Po0.001 at SRI, Mann-Whitney two-tailed test).
Iddm26.1 region encompassed by D2Mit8 and D2Arb16, whereas the telomeric region responsible encompasses the 32.7 Mb interval spanning from D2Rat354 to D2Rat63 (Figure 8c ).
Evidence for gene-environment interactions in the BBDP rat model All congenic lines described in the previous sections were housed at the OCI animal facility due to ongoing renovations at the Sunnybrook Research Institute's (SRI) comparative research facility. However, a limited number of BBDP, ACI.1u.Lyp and 2BA animals were maintained and monitored concurrently at SRI. In both facilities, animals were kept in microisolators, fed the same sterilized diet formulation and given acidified water. Furthermore, quarterly screening of each facility confirmed their SPF status. Surprisingly, despite the similarities in the environment to which the animals were exposed at both facilities, SRI-housed 2BA animals exhibited a more robust resistance to T1D compared with their counterparts in OCI (22% versus 78% cumulative incidence respectively, Po0.0001). In contrast, no significant environmentdependent difference in the incidence of diabetes was observed in the BBDP parental line between the two sites at the time of the study (73% at SRI versus 84.6% at OCI, P ¼ 0.81, Figure 9 ). While the environment influenced T1D susceptibility, this was not the case for the age of disease onset that remained similar at OCI and SRI for each of the two 2BA and BBDP strains (P ¼ 0.11 for the BBDP and P ¼ 0.32 for the 2BA). No evidence for a differential pattern of islet inflammation was found when pancreatic sections of diabetic and nondiabetic animals from either facility were examined (data not shown).
A multivariate Cox proportional hazards (survival) analysis revealed that although the genetic effect was still present after controlling for the different locations (Po0.0001), the magnitude of its effect on T1D varied depending on the site (P ¼ 0.02). This indicates that the environment strongly influences the effect of this chromosome 2 locus on disease risk.
The chromosome 2 congenic interval encompassing Iddm26, 32 and 33 is associated with an environment-dependent alteration in T-cell homeostasis and thymic involution To determine whether there are environment-dependent immune phenotypes evident in the parental and congenic lines housed at OCI or SRI, spleen and pooled lymph nodes were obtained from 140-day-old, parental and reciprocal chromosome 2 congenic BBDP (2BA) and ACI.1u.lyp (2AB) animals from both the facilities. Flow cytometric analysis was subsequently performed to examine various immune cell subsets. Comparison of SRI-housed 2BA and 2AB congenics with the parental BBDP and ACI.1u.Lyp strains respectively, revealed an increased T-cell compartment in the lymph nodes of animals harboring the BBDP interval ( Figure 10) . Specifically, introgression of the BBDP locus in the ACI.1u.Lyp background resulted in a significantly higher T-cell population in the periphery of the 2AB compared with that of its parental strain (P ¼ 0.0001), though it does not quite reach the same levels observed in the BBDP (P ¼ 0.016). Conversely, the presence of the ACI interval in the BBDP background restored lymph node T-cell proportions similar to those of the parental ACI.1u.Lyp strain (P ¼ 0.09).
This phenotype is environment-dependent, as animals housed in OCI did not exhibit similar variations in T-cell proportions dictated by their genotype at this chromosome 2 locus (BBDP versus 2BA P ¼ 0.13, BBDP versus ACI.1u.Lyp P ¼ 0.18, ACI.1u.Lyp versus 2BA P ¼ 0.74). Notably, the OCI-housed 2BA and ACI.1u.lyp strains exhibited significantly higher T-cell proportions compared with their SRI counterparts (P ¼ 0.0073 and P ¼ 0.0002, respectively), whereas the OCI-housed BBDP had lower proportions of the cell subset compared with its SRI counterparts (P ¼ 0.0006).
Consistent with this finding, it was observed that 140-day-old animals housed at OCI, regardless of strain, reproducibly had increased thymic cellularity compared with those housed at SRI (Supplementary Figure 8) , which would influence the production of mature T-cells. This would suggest that environmental differences between the two facilities exist, which affect T-cell homeostasis and/or degree of thymic involution. These significant alterations in T-cell populations may contribute to the differential T1D susceptibility observed.
DISCUSSION
The generation and study of several chromosome 2 congenic sublines obtained through introgression of ACI.1u.Lyp-derived fragments into the BBDP genetic background allowed the identification of several chromosome 2 quantitative trait loci that Figure 10 . An environment-dependent increase in T-cell proportions is contributed by the BBDP-derived chromosome 2 interval. The proportion of T-cells in the lymph nodes were assessed by flow cytometry in 140-day-old, nondiabetic animals housed at either the SRI or OCI animal facility (Filled symbols ¼ SRI-housed, Open symbols ¼ OCI-housed; ***Po0.001, **Po0.01, Mann-Whitney two-tailed test).
exert strong effects on T1D susceptibility and progression, as well as various immune parameters that may contribute to disease pathogenesis. At least two independent regions were identified to confer disease risk-Iddm26.1, a centromeric locus spanning 56 Mb from D2Mit8 (169 Mb) to D2Arb16 (225 Mb), and Iddm26.2, a 2 Mb telomeric locus between D2Arb16 (225 Mb) to D2Rat50 (227 Mb). In addition, a third locus, which modifies the penetrance of Iddm26.1, is expected in the telomeric region from D2Rat354 (226.4 Mb) and D2Rat69 (272.8 Mb). These regions coincide with, and explain the broad peak of linkage at Iddm26 previously determined through the assessment of a cohort of F2(BBDP Â ACI.1 u.Lyp) animals (Figure 11a ). Although the congenic intervals also include fragments of Iddm32 on the centromeric end and Iddm33 on the telomeric end, it is unlikely to contribute to the T1D-susceptibility phenotype. Overlap of the congenic intervals found to control disease risk with that of the F2 linkage analysis 1 shows that the regions of Iddm32 and 33 included in the congenic intervals have a LOD score p1, suggesting that these loci likely do not contribute to the phenotype observed.
Similarly, two subloci were also found to control the kinetics of disease progression and the age of disease onset (Figure 11b) . The first, which confers the strongest effect, overlaps with the 56 Mb centromeric Iddm26.1 locus conferring T1D susceptibility. However, this AOO locus may potentially be narrowed down to the 1.2 Mb interval between D2Rat99 (223.8 Mb) and D2Arb16 (225 Mb). The likelihood is minimal that the small fragment of Iddm32 included within this congenic interval provides a significant contribution to the phenotype. Examination of the F2 linkage analysis data shows a LOD score of approximately 1.4 in the Iddm32 region, compared with a peak of 3.4 within the Iddm26.1 locus. This would suggest that Iddm26.1 exerts a much stronger effect, and is likely the principal modulator of AOO within this congenic interval. The second sublocus exerts a mild, but significant effect and lies within a large telomeric region spanning D2Rat50 (227 Mb) to D2Rat63 (257.7 Mb). Although the influence of the peak of linkage within the telomeric region of Iddm26 identified in the F2 studies is the probable cause for the observed delay (LOD score ¼ 3.1), the contribution of the Iddm33 locus cannot be fully excluded. Thus, analysis of disease incidence in chromosome 2 congenic lines confirms the F2 linkage results, identifies distinct subloci involved in the different aspects of disease development, and defines the contributions of the various subloci within the previously reported region.
The degree of diabetes protection observed in the 2BA congenic line varied significantly between different animal facilities. Although a strong protection was observed in animals housed at SRI, the same congenic line was found to be susceptible to T1D within the OCI animal facility, even though the delay in disease kinetics was maintained across both locations. This is highly indicative of the influence of environmental factors on the penetrance of the chromosome 2 locus. During the initial phenotypic analysis of the congenic sublines, construction work was ongoing in and around the facility. Although animals used in the study were subsequently relocated to OCI, some animals were maintained at Sunnybrook and continually monitored for disease onset. Over time, disease onset eventually fell from 75 to 47% (data not shown) in the T1D-susceptible BBDP parental strain. One possibility is changes in microbial and viral exposure between the two facilities, which may alter disease progression in the BBDP and congenic sublines. Elimination of viral antigens through cesarean derivation and housing in virus antigen-free vivariums has been demonstrated to correlate with increased disease incidence and kinetics. 13 In addition, exposure to complete Freund's adjuvant, low-dose poly I:C and other microbial and viral antigens have been shown to provide a protective effect, [14] [15] [16] although these results are not always consistently observed. 17, 18 Serology reports ruled out known pathogens as a root cause for the differences in T1D incidences observed in the animals used for this study (Supplementary Table 2 ). However, due to the limitations of the screening process, an effect of unscreened bacteria or viruses on the disease process cannot be fully excluded, though the breeding carried out at OCI did not involve re-derivation of the lines by C-section or embryo transfer, but simple relocation of breeding pairs.
Consistent with our observations, Hillhouse et al. 19 recently reported that disturbance resulting from nearby construction resulted in a significant decrease in T1D incidence in their colony of NOD mice. It is thus possible that the stress response induced by the constant noise and vibrations from the ongoing construction could be another variable affecting the immunological state and T1D susceptibility of the animals being monitored. It was observed that animals housed in the Sunnybrook facility were more anxious during handling compared with those in OCI, suggesting a change in animal behavior due to environmental stressors (unpublished observations). In addition, it has been previously demonstrated that restraint 20, 21 and various other stress stimuli including temperature fluctuations 22 and physical stress 23 can result in the release of glucocorticoids leading to immune suppression, thymocyte apoptosis and thymic involution. This is consistent with the observation that 140-day-old nondiabetic animals in Sunnybrook had a consistently lower thymic cellularity compared with their age-matched counterparts housed in OCI (Supplementary Figure 8) . It is thus conceivable that the lower absolute number of T lymphocytes, as well as the glucocorticoid-induced immunosuppression of the animals may have contributed to the reduced incidence of T1D in the Sunnybrook colony. This may also explain the more pronounced protective effect of the ACI-derived Iddm26 locus in animals housed in Sunnybrook compared with those housed in OCI.
Although the 2BA carries a large ACI.1u.Lyp-derived fragment that spans both T1D susceptibility loci identified, the protective effect is nullified in this congenic line in the OCI animal facility. This would suggest that aside from the effects of environmental factors, the chromosome 2 T1D quantitative trait loci might be under epistatic control by other genetic regions within this chromosomal interval. As protection is maintained in the 2BAc line, which carries the full Iddm26.1 region, as well as the majority of Iddm26.2 locus except the distal 0.6 Mb, this modifying region is likely located within this telomeric fragment (Figure 11a ). Despite the strong protective effect of both ACI.1u.Lyp-derived Iddm26.1 and Iddm26.2 loci in congenic animals, analysis of the F2 cohort only showed suggestive linkage of T1D (LOD score of 2.9 at the peak of linkage) to chromosome 2. This may also be partially explained by the counteracting epistatic effects of this region, which may have masked the full impact of Iddm26.1 and Iddm26.2.
Interestingly, the centromeric Iddm26.1 locus that influences age of disease onset overlaps with that which controls the proportion of splenic macrophages. The ACI haplotype at this locus results in a significant 10-day delay of diabetes onset, and also confers a lower proportion of splenic macrophages. This coincides with the results of the F2(BBDP Â ACI.1u.Lyp) cohort studies, which identified a peak of linkage of the splenic macrophage phenotype on chromosome 2 that overlapped with the AOO peak (Figure 11b ). Thus, it is possible that these phenotypes are under the same genetic control, or that the delay in disease onset observed is dependent upon the frequency of these immune cell types. Macrophages are among the first cell types to infiltrate the pancreatic islets, and their essential role in the diabetogenic process has been previously demonstrated both in the BBDP rat and NOD mouse models. 10, 12 Therefore, alterations in the homeostasis of macrophages that have the ability to initiate and possibly propagate the pancreatic inflammatory process may contribute to the delay in disease onset observed.
The locus controlling AOO, which overlaps with that controlling the macrophage phenotype, may potentially be narrowed down to a 1.2-Mb interval containing 12 protein-coding genes, 1 uncharacterized protein and 1 pseudogene. Among the 12 characterized genes, 3 have functions within the immune system and are thus good candidate genes within the region. One in particular, Nr1h5, also known as the Farnesoid X Receptor b (FXRb), is of interest, as this gene has known immunoregulatory roles in macrophages. FXRb is a bile acid-regulated member of the nuclear receptor superfamily of ligand-activated transcription factors. It is mainly expressed in enterohepatic tissues, but has also been found in cells of the innate immune system, where it interferes with NF-kB and AP-1 to suppress inflammatory pathways. 24 FXR À / À mice exhibit increased proportions of CD11b þ cells, and have macrophages with enhanced activation at the resting state, demonstrating its role as a negative regulator of macrophage function and homeostasis. 25 Other genes of consideration within the region are Sike1 and Nras. Sike1 is the suppressor of IKKe and TBK1, and functions to suppress TLR3-mediated IRF3 activation and interferon-stimulated response elements. 26 Nras is a member of the Ras family of small GTPases, which acts as a signal transducer for various cell surface receptors and has roles in cell cycle regulation and cell differentiation. Activating mutations in this gene have been associated with acute myeloid leukemia, autoimmune lymphoproliferative syndrome and myelodysplastic syndromes in humans. 27, 28 At least two independent loci in the chromosome 2 interval have significant influences on serum IgE levels. Although more studies are required to substantially narrow down the regions responsible for the phenotype, it is clear that the ACI haplotype at either or both of these loci promotes a reduction in circulating IgE antibodies compared with the parental BBDP strain. IgE is most notably known for its function in the clearance of parasitic infections, as well as its role in the allergic response. Binding of IgE and antigen complexes to FceRI receptors on the surface of mast cells and basophils cause cell degranulation and the release of vasoactive amines, neutral proteases, cytokines and the generation of prostaglandins and leukotrienes, which mediate the inflammatory response. 29 It is possible that the IgE phenotype observed in the congenic lines has no pathogenic role in T1D, or that it is merely a reflection of heightened inflammatory states in T1D-susceptible strains such as the BBDP. However, the possibility remains that circulating IgE may contribute to disease progression. Consistent with our own findings, a study by Geoffrey et al. 30 demonstrated that diabetes-prone BBDR lyp/lyp animals exhibited a progressive increase in IgE levels over time, whereas resistant rat strains examined maintained low, steady levels of the immunoglobulin isotype. In turn, this has been suggested to promote disease through the activation of mast cells, as the inhibition of mast cell degranulation by cromolyn resulted in a significant delay in disease onset. A recent study by Tuller et al. 31 utilized a large-scale systems biology approach to identify genes and pathways that characterize different human autoimmune disorders. In line with the findings in rodent models, their analysis revealed the enrichment of members of the FceRI pathway in both T1D and juvenile rheumatoid arthritis patients, providing further evidence for a potential role of IgE in disease pathology.
Iddm26.1 is a large, gene-rich locus spanning 56 Mb, which appear to influence several diabetes-related parameters including disease susceptibility, age of T1D onset, the proportion of splenic macrophages and serum IgE levels. However, the vastness of this interval makes it difficult to identify the causal regions and genes that regulate the different phenotypes. Examination of the region yielded several promising candidate genes. These include the negative regulator of T-cell proliferation, Cd101; the alpha subunit of inflammatory cytokine IL-12, Il12a; the IL-6 receptor subunit, Il6r; and the toll-like receptor Tlr2 among many others.
The Iddm26.2 locus immediately telomeric to Iddm26.1 is a shorter interval spanning only 2 Mb that contains 23 proteincoding genes. This region appears to control T1D susceptibility, thymic cellularity and the proportion of CD4 þ CD25 þ T-cells in the peripheral lymph nodes. However, it does not appear to exert any influence on the age of disease onset. Among the promising candidate genes within this region is the protein tyrosine phosphatase, Ptpn22. This protein functions as a negative regulator of antigen receptor signaling in both B and T lymphocytes, which is fitting with the immune phenotypes found to be associated with this locus. Furthermore, polymorphisms within this gene have been associated with several human autoimmune disorders including rheumatoid arthritis and T1D. 32, 33 
MATERIALS AND METHODS Animals
Diabetes-prone BBDP/Wor/Sunn (BBDP) rats were originally purchased from BRM (Worcester, MA, USA), and have been maintained for 420 generations of brother Â sister breedings at our animal facility and are homozygous at every genetic marker that has been tested. The ACI.1u.lyp strain was derived from the inbred August Copenhagen Irish (ACI/Hsd) rats from Harlan Sprague Dawley (Indianapolis, IN, USA) in which the RT1u (Iddm1) and Gimap5 (Lyp, Iddm2) loci from the original Ottawa diabetesprone BB colony were introgressed. 34 The ACI.1u.Lyp strain exhibits no manifestations of autoimmunity, and have also been maintained for 420 generations of brother Â sister breedings at our animal facility since this time. To develop the F2 cohort, BBDP males and ACI.1u.lyp females were crossed to generate F1 progeny that were then intercrossed to produce F2(BBDP Â ACI.1u.lyp) rats for linkage analysis. The results of this analysis have been previously reported.
1 Non-lymphopenic, ACI.1u and BB Non-Lyp inbred strains that are homozygous for wild-type Gimap5, as previously described. 9, 34 To establish the breeding of congenic lines at the OCI facility, 3-4-weekold animals of the appropriate genotypes and born at Sunnybrook were transferred to OCI in sterile containers and subsequently used as initial breeders of the OCI colony.
Generation of chromosome 2 congenic sublines
The 1-LOD interval of Iddm26, defined by linkage analysis of the F2(BBDP Â ACI.1u.Lyp) cross, spans 40 Mb (27 cM) from D2Rat44 to D2Rat88, and overlaps with Iddm33 at the telomeric region (http://www. t1dbase.org/page/Welcome/display/?species ¼ Rat).
1 To produce BBDP.ACI. 1u.Lyp-chromosome 2 congenic animals for this region, male F1(BBDP Â ACI.1u.Lyp) animals were initially backcrossed to female BBDP/Wor/Sunn animals to ensure that their male backcross 1 offspring had a BBDP-derived X chromosome. Backcross animals were genotyped with markers throughout the 12 Iddm loci identified in the F2(BBDP Â ACI.1u.lyp) intercross (Iddm25 to Iddm36) at an average spacing of 10 Mb (Supplementary Table 1) , and animals retaining heterozygosity at microsatellite markers D2Wox17 and D2Rat69 flanking the telomeric end of Iddm26 and the centromeric extremity of Iddm33, respectively, were then genotyped within the region at an average spacing of 12 Mb to ensure that a double recombination had not taken place. Male backcross 1 animals heterozygous throughout the 1-LOD intervals of Iddm26 and 33 were then selected for backcrossing to BBDP/Wor/Sunn animals to produce the backcross 2 generation, and backcrossing to BBDP/Wor/Sunn was repeated using either male or female animals until backcross 10 was reached. None of the other loci (Iddm25, Iddm27-32 and Iddm34-36) retained heterozygosity beyond backcross 8, with most becoming fixed with BBDP genotype by backcross 3. Male and female backcross 10 animals, which were heterozygous for both Iddm26 and 33 were then bred together to fix the region as homozygous ACI genotype. Further genotyping centromeric to Iddm26 defines the resultant congenic line as spanning at least 98.5 Mb from the telomere of chromosome 2. A similar process was utilized to establish the 2AB congenic line. However, in this line, the BBDP-derived chromosome 2 interval spanning the length of Iddm26, Iddm32 and a fragment of Iddm33 was introgressed into the ACI.1u.Lyp background (Supplementary Figure 4) .
To dissect the Iddm26 locus, congenic sublines carrying informative fragments were generated through breeding of BBDP.ACI-Iddm26/32/33 congenic animals with the BBDP strain. Resulting littermates that had undergone recombinations within the locus were backcrossed to the BBDP and then intercrossed to generate congenic sublines homozygous for the regions of interest, as previously described. 35 Monitoring and diagnosis of diabetes To assess diabetes onset, rats were weighed and tested three times a week for the presence of glycosuria and ketonuria starting at two months of age as previously described. 1 Once animals became glycosuric, the diagnosis of diabetes was established on the basis of hyperglycemia (blood glucose 416.7 mM) for 2 consecutive days. Non-diabetic littermates were killed at 140 days. The Sunnybrook and OCI Animal Care Committee approved all the experimental procedures.
All animals were housed in specific pathogen-free conditions, and all sentinels were negative for screened parasites and circulating antibodies against known bacterial and viral pathogens, including the diabetogenic Kilham rat virus (Supplementary Table 2 ).
Monoclonal antibodies, Flow Cytometry and Analysis
Most monoclonal antibodies (mAbs) used in this study were affinity purified from hybridoma culture supernatants on rat anti-mouse Ig-Sepharose, and then conjugated with FITC, biotin, APC or PE using standard procedures. These mAbs include anti-CD4 (W3/25), anti-TCR (R73), anti-CD8a (OX8), anti-CD45RC (OX22), anti-SIRPa (OX41), anti-kappa chain (MK-1), anti-NKRP1 (3.2.3) and anti-Thy1 (OX7). The OX8, W3/25, OX22 and OX7 hybridomas were kindly provided by Dr D Mason (University of Oxford, Oxford, UK), whereas the R73 hybridoma was provided by Dr T Hü nig (University of Wü rzburg, Wü rzburg, Germany). The FITC-conjugated anti-CD25 (clone OX39) was purchased from BD Pharmingen (Mississauga, ON, Canada) and Streptavidin-Spectral Red PE/ Cy5 Tandem was purchased from Southern Biotech (Cedarlane Laboratories, Burlington, ON, Canada).
To label cell surface markers, mononuclear cell suspensions were treated with a blocking mouse anti-rat CD32 mAb (Clone D34-485, BD Pharmingen) and then simultaneously stained with Biotin-, FITC-, APC-and/or PEconjugated mAbs. In cases when biotinylated antibodies were used, this step was followed by incubation with streptavidin-Spectral Red. All cell surface staining steps were done in staining buffer (phosphate-buffered saline with 2.5% heat-inactivated bovine serum) for 10 min at room temperature. All samples were acquired on a BD FACSCalibur flow cytometer (BD Biosciences, Mississauga, ON, Canada) and analyzed using FlowJo (Tree Star, Ashland, OR, USA). Viable cells were gated using forward and side scatter.
IgE ELISA EIA/RIA microplates (Corning Life Sciences, Corning, NY, USA) were coated with 2 mg ml À 1 of the anti-rat IgE capture antibody B41-1 (BD Pharmingen) overnight at 4 1C. To prevent nonspecific binding, the wells were blocked with phosphate-buffered saline containing 2% bovine serum albumin (Sigma Aldrich, Oakville, ON, Canada) for 1 h at room temperature. The blocking step was followed by the addition of undiluted sera or the appropriate standards in triplicates. After washing with phosphatebuffered saline with 0.05% Tween-20, IgE levels were detected using the biotinylated B41-3 anti-rat IgE antibody (BD Pharmingen) followed by HRPconjugated streptavidin (BD Pharmingen). The colorimetric substrate TMB (Sigma Aldrich) was added following the final washing steps to detect the plate-bound Ig. To prevent saturation, the reaction was stopped using a final concentration of 0.5 N HCl and read at 450 nm using a PowerWave X340 spectrophotometer (Biotek, Winooski, VT, USA).
Assessment of thymic export through FITC intrathymic injections
A short upper thoracotomy was performed under general anesthesia to expose the thymus, and 10 ml of a sterile FITC solution (1 mg ml À 1 in phosphate-buffered saline) was injected into two sites of each thymic lobe using a 0.5-ml insulin syringe and a 28-1/2-gauge needle. Animals were sacrificed 24 h after the FITC injection. Lymphocytes were isolated from the thymus, pooled (cervical, axillary, inguinal, paraaortic and mesenteric) lymph nodes and spleen, and counted. The proportion of FITC þ CD4 þ and CD8 þ T lymphocytes, hence RTEs, among the mononuclear cell of each of these lymphoid organs was then determined by three-color immunofluorescence and flow cytometry. The absolute number of RTE was then calculated according to the formula: absolute number of RTE ¼ [(% Peripheral TCR þ FITC þ )/(% FITC þ Thymocytes)] Â (Total Cell Number).
Statistical analyses
The statistical significance of differences in the kinetics of disease onset and susceptibility to T1D between the various congenic and parental strains were determined by Mantel-Cox log-rank analysis, differences in immune parameters were calculated using Kruskall-Wallis test, whereas pair-wise comparisons were done by Mann-Whitney two-tailed analysis. Prism 6 Software (GraphPad Software Inc.) was used to perform all statistical calculations. Linkage analyses of F2(ACI.1u.Lyp Â BBDP) animals have been previously outlined in detail.
